438 results on '"Zengerling, Friedemann"'
Search Results
2. Impairment of α-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasion
3. Chancen der PSMA(prostataspezifisches Membranantigen)-Hybridbildgebung beim Prostatakarzinom
4. First-Line Immune Combination Therapies for Nonclear Cell Versus Clear Cell Metastatic Renal Cell Carcinoma: Real-World Multicenter Data From Germany
5. Gender-specific outcomes in immune checkpoint inhibitor therapy for advanced or metastatic urothelial cancer: a systematic review and meta-analysis
6. Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
7. TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regeneration
8. Hodentumor: Diagnostisches Vorgehen
9. Loss of ORP3 induces aneuploidy and promotes bladder cancer cell invasion through deregulated microtubule and actin dynamics
10. Neoadjuvante Chemotherapie beim High-risk-Urothelkarzinom des oberen Harntraktes: aktuelle Evidenzlage
11. Erratum zu: Chancen der PSMA(prostataspezifisches Membranantigen)-Hybridbildgebung beim Prostatakarzinom
12. Chirurgische oder radiologische Behandlung von Varikozelen bei subfertilen Männern
13. Nachsorge von Hodentumoren in der urologischen Praxis – historische Entwicklung und aktuelle Aspekte
14. Testicular germ cell tumours’ clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival—a systematic review
15. Prognostic factors in patients with clinical stage I nonseminoma—beyond lymphovascular invasion: a systematic review
16. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence
17. First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment: A comprehensive review compiled by the German Testicular Cancer Study Group
18. Can magnetic resonance imaging replace conventional computerized tomography for follow-up of patients with testicular cancer? A systematic review
19. Therapy of clinical stage IIA and IIB seminoma: a systematic review
20. Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial
21. Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
22. Urothelkarzinom des oberen Harntraktes: aktuelle Behandlungsstrategien
23. Hodentumor: Diagnostisches Vorgehen
24. Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial
25. INSIGHT-005: A new stratum of the explorative, open-labeled, phase I INSIGHT study to evaluate the feasibility and safety, as well as preliminary efficacy, of subcutaneous injections with IMP321 (eftilagimod alpha) in combination with PD-L1 inhibitor (avelumab) for metastatic or unresectable locally advanced urothelial carcinoma (UC)—IKF-s614.
26. Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma
27. Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor
28. Organoide als Meilenstein auf dem Weg zur personalisierten Therapie des Urothelkarzinoms: ein systematischer Review
29. Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial
30. Predictors for the utilization of social service counseling by prostate cancer patients
31. Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG)
32. Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging
33. Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
34. Vorzeitiger Samenerguss (Ejaculatio praecox) bei erwachsenen Männern: Selektive Serotonin-Wiederaufnahmehemmer
35. NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer
36. Adherence to European Association of Urology and National Comprehensive Cancer Network Guidelines Criteria for Inguinal and Pelvic Lymph Node Dissection in Penile Cancer Patients—A Survey Assessment in German-speaking Countries on Behalf of the European Prospective Penile Cancer Study Group
37. Hodentumor: Diagnostisches Vorgehen
38. Adressen
39. Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial.
40. Supplementary Table S4 from Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study
41. Supplementary Figure S1 from Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study
42. Data from Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study
43. Psychometric validation of the German version of the EPIC-26 questionnaire for patients with localized and locally advanced prostate cancer
44. Radiomics and Clinicopathological Characteristics for Predicting Lymph Node Metastasis in Testicular Cancer
45. Detection of recurrence through microRNA-371a-3p serum levels in a follow-up of stage I testicular germ cell tumors in the DRKS-00019223 study
46. Occurrence of NECTIN4 amplification in solid tumors and enfortumab vedotin response in metastatic urothelial cancer.
47. CRP kinetics to predict long-term efficacy of first-line immune-checkpoint inhibition combination therapies in metastatic renal cell carcinoma: An updated multicenter real-world experience applying different CRP kinetics definitions.
48. Machine Learning Classifiers for Predictive Biomarkers Combining Clinical and Radiomic Data in Testicular Cancer
49. Phosphodiesteraseinhibitoren zur Behandlung des benignen Prostatasyndroms
50. The BET-inhibitor PFI-1 diminishes AR/AR-V7 signaling in prostate cancer cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.